Literature DB >> 14513982

Additional experience with dexmedetomidine in pediatric patients.

Joseph D Tobias1, John W Berkenbosch, Pierantonio Russo.   

Abstract

PURPOSE: This study evaluates the efficacy of dexmedetomidine in clinical scenarios other than sedation during mechanical ventilation.
METHODS: We conducted a retrospective chart review and presentation of case series of children in the pediatric intensive care unit and the postanesthesia care unit who received dexmedetomidine.
RESULTS: Dexmedetomidine was administered by continuous infusion to three patients and as a single bolus dose (0.5 microg/kg) to two patients. In the five clinical scenarios, dexmedetomidine provided effective sedation during spontaneous ventilation in two patients, reversed the clinical signs and symptoms of withdrawal from illicit substances in one patient, and was effective in the treatment of postanesthesia emergence delirium and shivering in two additional patients.
CONCLUSION: These preliminary data suggest that dexmedetomidine may be an effective agent for sedation in spontaneously breathing patients, in the treatment of drug withdrawal, and in the treatment of two common postanesthesia problems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513982     DOI: 10.1097/01.SMJ.0000053557.75799.09

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  12 in total

1.  Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.

Authors:  Nelson H Burbano; Andrea V Otero; Donald E Berry; Richard A Orr; Ricardo A Munoz
Journal:  Intensive Care Med       Date:  2011-12-13       Impact factor: 17.440

2.  Dexmedetomidine use in pediatric intensive care and procedural sedation.

Authors:  Marcia L Buck
Journal:  J Pediatr Pharmacol Ther       Date:  2010-01

Review 3.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

Review 4.  Clinical uses of dexmedetomidine in pediatric patients.

Authors:  Hanna Phan; Milap C Nahata
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

5.  Effects of dexmedetomidine added to caudal ropivacaine in paediatric lower abdominal surgeries.

Authors:  Vijay G Anand; M Kannan; A Thavamani; Merlin J Bridgit
Journal:  Indian J Anaesth       Date:  2011-07

6.  A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging.

Authors:  Jaydev Dave; Sandip Vaghela
Journal:  Saudi J Anaesth       Date:  2011-07

7.  High dose dexmedetomidine: effective as a sole agent sedation for children undergoing MRI.

Authors:  Sheikh Sohail Ahmed; Tamara Unland; James E Slaven; Mara E Nitu
Journal:  Int J Pediatr       Date:  2015-01-29

8.  Effect of caudal clonidine on emergence agitation and postoperative analgesia after sevoflurane anaesthesia in children: Randomised comparison of two doses.

Authors:  Anudeep Saxena; Ashish Sethi; Vikesh Agarwal; Rajan B Godwin
Journal:  Indian J Anaesth       Date:  2014 Nov-Dec

9.  Phase IV, Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Patients Undergoing Procedure-Type Sedation.

Authors:  Edmund H Jooste; Gregory B Hammer; Christian R Reyes; Vaibhav Katkade; Peter Szmuk
Journal:  Front Pharmacol       Date:  2017-08-11       Impact factor: 5.810

10.  Effects of the Two Doses of Dexmedetomidine on Sedation, Agitation, and Bleeding During Pediatric Adenotonsillectomy.

Authors:  Amir Shafa; Hastisadat Aledavud; Hamidreza Shetabi; Sedige Shahhosseini
Journal:  Anesth Pain Med       Date:  2021-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.